Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 8:04 AM UTC
| NCT Number | NCT07217171 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE1 |
| Target Enrollment | 160 participants |
| Active Locations | 15 sites in the US |
| Sponsor | EvolveImmune United, Inc |
| Last Updated on CT.gov | August 18, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07217171 is currently recruiting participants. This phase1 study for bladder cancer is actively seeking new participants at 15 locations across the United States. The study is sponsored by EvolveImmune United, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07217171 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07217171 was last updated 1 week ago (August 18, 2026). HelloStudys verifies this status automatically.